Chemotaxis inhibitory protein of Staphylococcus aureus binds specifically to the C5a and formylated peptide receptor

Journal of Immunology

Volumn 172, Issue 11, 2004, Pages 6994-7001

  Postma, Bent ^a   Poppelier, Miriam J ^a   Van Galen, Joost C ^a   Prossnitz, Eric R ^b   Van Strijp, Jos A G ^a   De Haas, Carla J C ^a   Van Kessel, Kok P M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIBODY; ANTIINFLAMMATORY AGENT; BACTERIAL PROTEIN; CHEMOATTRACTANT; CHEMOTAXIS INHIBITORY PROTEIN; COMPLEMENT COMPONENT C5A; COMPLEMENT COMPONENT C5A RECEPTOR; FORMYLMETHIONYLLEUCYLPHENYLALANINE; FORMYLPEPTIDE; FORMYLPEPTIDE RECEPTOR; G PROTEIN COUPLED RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALCIUM MOBILIZATION; CELL STRAIN U937; CHEMOTAXIS; CONTROLLED STUDY; HUMAN; HUMAN CELL; INTERNALIZATION; LIGAND BINDING; MONOCYTE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; STAPHYLOCOCCUS AUREUS; TARGET CELL;

STAPHYLOCOCCUS AUREUS;

EID: 2442695297     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.11.6994     Document Type: Article

References (38)

1. De Haas, C. J. C., K. E. Veldkamp, A. Peschel, F. Weerkamp, W. J. B. van Wamel, H. C. Heezius, M. J. J. G. Poppelier, K. P. van Kessel, and J. A. van Strijp. 2004. Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial anti-inflammatory agent. J. Exp. Med. 199:687.
2. Veldkamp, K. E., H. C. Heezius, J. Verhoef, J. A. van Strijp, and K. P. van Kessel. 2000. Modulation of neutrophil chemokine receptors by Staphylococcus aureus supemate. Infect. Immun. 68:5908.
3. Murdoch, C., and A. Finn. 2000. Chemokine receptors and their role in inflammation and infectious diseases. Blood 95:3032.
4. Smedly, L. A., M. G. Tonnesen, R. A. Sandhaus, C. Haslett, L. A. Guthrie, R. B. Johnston, Jr., P. M. Henson, and G. S. Worthen. 1986. Neutrophil-mediated injury to endothelial cells: enhancement by endotoxin and essential role of neutrophil elastase. J. Clin. Invest. 77:1233.
5. Butcher, E. C. 1991. Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity. Cell 67:1033.
6. Malech, H. L., and J. I. Gallin. 1987. Current concepts: immunology: neutrophils in human diseases. N. Engl. J. Med. 317:687.
7. Jacob, H. S., and D. E. Hammerschmidt. 1981. Complement-induced granulocyte aggregation: importance in myocardial infarction and shock lung. JAMA 245:2013.
8. Troelstra, A., B. N. Giepmans, K. P. van Kessel, H. S. Lichenstein, J. Verhoef, and J. A. van Strijp. 1997. Dual effects of soluble CD14 on LPS priming of neutrophils. J. Leukocyte Biol. 61:173.
9. Kew, R. R., T. Peng, S. J. DiMartino, D. Madhavan, S. J. Weinman, D. Cheng, and E. R. Prossnitz. 1997. Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships. J. Leukocyte Biol. 61:329.
10. Herlin, T., and N. Borregaard. 1983. Early changes in cyclic AMP and calcium efflux during phagocytosis by neutrophils from normals and patients with chronic granulomatous disease. Immunology 48:17.
11. Van Amersfoort, E. S., and J. A. van Strijp. 1994. Evaluation of a flow cytometric fluorescence quenching assay of phagocytosis of sensitized sheep erythrocytes by polymorphonuclear leukocytes. Cytometry 17:294.
12. Hunter, R. 1970. Standardization of the chloramine-T method of protein iodination. Proc. Soc. Exp. Biol. Med. 133:989.
13. Falk, W., L. Harvath, and E. J. Leonard. 1982. Only the chemotactic subpopulation of human blood monocytes expresses receptors for the chemotactic peptide N-formylmethionyl-leucyl-phenylalanine. Infect. Immun. 36:450.
14. Huey, R., and T. E. Hugli. 1985. Characterization of a C5a receptor on human polymorpbonuclear leukocytes (PMN). J. Immunol. 135:2063.
15. Pike, M. C., D. G. Fischer, H. S. Koren, and R. Snyderman. 1980. Development of specific receptors for N-formylated chemotactic peptides in a human monocyte cell line stimulated with lymphokines. J. Exp. Med. 152:31.
16. Van Epps, D. E., S. J. Simpson, and R. Johnson. 1993. Relationship of C5a receptor modulation to the functional responsiveness of human polymorphonuclear leukocytes to C5a. J Immunol. 150:246.
17. Katada, T., and M. Ui. 1982. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc. Natl. Acad. Sci. USA 79:3129.
18. Jagels, M. A., J. Travis, J. Potempa, R. Pike, and T. E. Hugli. 1996. Proteolytic inactivation of the leukocyte C5a receptor by proteinases derived from Porphyromonas gingivalis. Infect. Immun. 64:1984.
19. Coenjaerts, F. E., A. M. Walenkamp, P. N. Mwinzi, J. Scharringa, H. A. Dekker, J. A. van Strijp, R. Cherniak, and A. I. Hoepelman. 2001. Potent inhibition of neutrophil migration by cryptococcal mannoprotein-4-induced desensitization. J. Immunol. 167:3988.
20. Lipovsky, M. M., G. Gekker, S. Hu, L. C. Ehrlich, A. I. Hoepelman, and P. K. Peterson. 1998. Cryptococcal glucuronoxylomannan induces interleukin (IL)-8 production by human microglia but inhibits neutrophil migration toward IL-8. J. Infect. Dis. 177:260.
21. Khandaker, M. H., L. Xu, R. Rahimpour, G. Mitchell, M. E. DeVries, J. G. Pickering, S. K. Singhal, R. D. Feldman, and D. J. Kelvin. 1998. CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism. J. Immunol. 161:1930.
22. Sica, A., A. Saccani, A. Borsatti, C. A. Power, T. N. Wells, W. Luini, N. Polentarutti, S. Sozzani, and A. Mantovani. 1997. Bacterial lipopolysaccharide rapidly inhibits expression of C-C chemokine receptors in human monocytes. J. Exp. Med. 185:969.
23. Leff, P. 1995. The two-state model of receptor activation. Trends Pharmacol. Sci. 16:89.
24. Lefkowitz, R. J., S. Cotecchia, P. Samama, and T. Costa. 1993. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:303.
25. Schutz, W., and M. Freissmuth. 1992. Reverse intrinsic activity of antagonists on G protein-coupled receptors. Trends Pharmacol. Sci. 13:376.
26. Leff, P. 1995. Inverse agonism: theory and practice. Trends Pharmacol. Sci. 16:256.
27. Wenzel-Seifert, K., C. M. Hurt, and R. Seifert. 1998. High constitutive activity of the human formyl peptide receptor. J. Biol. Chem. 273:24181.
28. Wenzel-Seifert, K., and R. Seifert. 1993. Cyclosporin H is a potent and selective formyl peptide receptor antagonist: comparison with N-t-butoxycarbonyl-L-phenylalanyl-L-leucyl-L-phenylalanyl-L-leucyl-L- phenylalanine and cyclosporins A, B, C, D, and E. J. Immunol. 150:4591.
29. de Paulis, A., A. Ciccarelli, G. de Crescenzo, R. Cirillo, V. Patella, and G. Marone. 1996. Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. J. Allergy Clin. Immunol. 98:152.
30. + as universal stabilizer of the inactive (R) state. Receptors Channels 7:357.
31. Murphy, P. M. 1994. The molecular biology of leukocyte chemoattractant receptors. Annu. Rev. Immunol. 12:593.
32. DeMartino, J. A., G. Van Riper, S. J. Siciliano, C. J. Molineaux, Z. D. Konteatis, H. Rosen, and M. S. Springer. 1994. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. J. Biol. Chem. 269:14446.
33. Siciliano, S. J., T. E. Rollins, J. DeMartino, Z. Konteatis, L. Malkowitz, G. Van Riper, S. Bondy, H. Rosen, and M. S. Springer. 1994. Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. Proc. Natl. Acad. Sci. USA 91:1214.
34. Quehenberger, O., E. R. Prossnitz, S. L. Cavanagh, C. G. Cochrane, and R. D. Ye. 1993. Multiple domains of the N-formyl peptide receptor are required for high-affinity ligand binding: construction and analysis of chimeric N-formyl peptide receptors. J. Biol. Chem. 268:18167.
35. Mills, J. S., H. M. Miettinen, D. Barnidge, M. J. Vlases, S. Wimer-Mackin, E. A. Dratz, J. Sunner, and A. J. Jesaitis. 1998. Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. J. Biol. Chem. 273:10428.
36. Stevens, J. H., P. O'Hanley, J. M. Shapiro, F. G. Mihm, P. S. Satoh, J. A. Collins, and T. A. Raffin. 1986. Effects of anti-C5a antibodies on the adult, respiratory distress syndrome in septic primates. J. Clin. Invest. 77:1812.
37. Pemberton, M., G. Anderson, V. Vetvicka, D. E. Justus, and G. D. Ross. 1993. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J. Immunol. 150:5104.
38. Jose, P. J., I. K. Moss, R. N. Maini, and T. J. Williams. 1990. Measurement of the chemotactic complement fragment C5a in rheumatoid synovial fluids by radioimmunoassay: role of C5a in the acute inflammatory phase. Ann. Rheum. Dis. 49:747.